A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer

Clinical trial NCT01188707 · TERMINATED

Trial details

NCT number: NCT01188707
Sponsor: Herlev Hospital
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2010-10-01
Primary completion: 2011-06-30
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.